Delivery of RNA interference

被引:162
|
作者
Li, Charles X. [1 ]
Parker, Amy [1 ]
Menocal, Ellen [1 ]
Xiang, Shuanglin [1 ]
Borodyansky, Laura [1 ]
Fruehauf, Johannes H. [1 ]
机构
[1] Harvard Univ, Sch Med, Div Gastroenterol, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
关键词
RNA interference; gene therapy; gene delivery; therapeutic RNAi; transkingdom RNA interference;
D O I
10.4161/cc.5.18.3192
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Over the last few years, RNA Interference (RNAi), a naturally occurring mechanism of gene regulation conserved in plant and mammalian cells, has opened numerous novel opportunities for basic research across the field of biology. While RNAi has helped accelerate discovery and understanding of gene functions, it also has great potential as a therapeutic and potentially prophylactic modality. Challenging diseases failing conventional therapeutics could become treatable by specific silencing of key pathogenic genes. More specifically, therapeutic targets previously deemed "undruggable" by small molecules, are now coming within reach of RNAi based therapy. For RNAi to be effective and elicit gene silencing response, the double-stranded RNA molecules must be delivered to the target cell. Unfortunately, delivery of these RNA duplexes has been challenging, halting rapid development of RNAi-based therapies. In this review we present current advancements in the field of siRNA delivery methods, including the pros and cons of each method.
引用
收藏
页码:2103 / 2109
页数:7
相关论文
共 50 条
  • [1] Tumour delivery of RNA interference
    Charlotte Harrison
    Nature Reviews Drug Discovery, 2012, 11 (10) : 750 - 750
  • [2] RNA-interference effectors and their delivery
    Doody, A.
    Putnam, D.
    CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, 2006, 23 (02): : 137 - 164
  • [3] Hepatic RNA interference: delivery by synthetic vectors
    Haynes, Matthew T.
    Huang, Leaf
    DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2014, 4 (01) : 61 - 73
  • [4] Hepatic RNA interference: delivery by synthetic vectors
    Matthew T. Haynes
    Leaf Huang
    Drug Delivery and Translational Research, 2014, 4 : 61 - 73
  • [5] Transkingdom RNA interference (tkRNAi) as a new delivery tool for therapeutic RNA
    Aigner, Achim
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2009, 9 (12) : 1533 - 1542
  • [6] The design and characterization of an RNA nanoring for use in RNA interference drug delivery
    Grabow, Wade
    Severcan, Isil
    Chworos, Arkadiusz
    Shapiro, Bruce
    Luc, Jaeger
    FASEB JOURNAL, 2010, 24
  • [7] Versatile RNA Interference Nanoplatform for Systemic Delivery of RNAs
    Choi, Ki Young
    Silvestre, Oscar F.
    Huang, Xinglu
    Min, Kyung Hyun
    Howard, Gregory P.
    Hida, Naoki
    Jin, Albert J.
    Carvajal, Nicole
    Lee, Sang Wook
    Hong, Jong-In
    Chen, Xiaoyuan
    ACS NANO, 2014, 8 (05) : 4559 - 4570
  • [8] Delivery strategies for RNA interference (RNAi) based therapeutics
    Manoharan, Muthiah
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 246
  • [9] Focus on RNA interference: from nanoformulations to in vivo delivery
    Karp, Jeffery M.
    Peer, Dan
    NANOTECHNOLOGY, 2018, 29 (01)
  • [10] Hepatic Delivery of RNA Interference Activators for Therapeutic Application
    Arbuthnot, Patrick
    Ely, Abdullah
    Weinberg, Marc S.
    CURRENT GENE THERAPY, 2009, 9 (02) : 91 - 103